Revenue growth of 20% year-over-year Net loss of $27.7 million and non-GAAP net income of $5.0 million Net loss margin of (11.8)%; Adjusted EBITDA margin of 40% LEHI, Utah and LOUISVILLE, Ky., Aug. 7, 2024 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
SALT LAKE CITY, Nov. 24, 2025 /PRNewswire/ — In the heart of Utah’s Wasatch Front, longtime local physician Megan J. Engelen, DO, FACP, is proud to open a new practice model in partnership with MDVIP […]
Welcome to this week’s Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Max Bayer or Gabrielle Masson, and we will feature it here […]
Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule BLX-7006 reduced the weight of obese mice by 15% over a 28-day span. “We are thrilled […]
Copyright © 2026 Biotech Networks
